Cargando…
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey
Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-2 infection. Vaccination against this infection can prevent the patients from developing severe disease. But vaccine hesitancy in this group can emerge as a hurdle. So there is a need to understand the perception...
Autores principales: | Gaur, Priyanka, Agrawat, Hardik, Shukla, Anuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249840/ https://www.ncbi.nlm.nih.gov/pubmed/34213580 http://dx.doi.org/10.1007/s00296-021-04938-9 |
Ejemplares similares
-
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021) -
Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
por: Menon, Aparna R., et al.
Publicado: (2022) -
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
por: Esquivel-Valerio, Jorge Antonio, et al.
Publicado: (2021) -
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
por: Sen, Parikshit, et al.
Publicado: (2021) -
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)